{"id":"levocetirizine-xyzal","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Somnolence"},{"rate":"5-8","effect":"Headache"},{"rate":"3-5","effect":"Fatigue"},{"rate":"2-4","effect":"Dry mouth"},{"rate":"2-3","effect":"Pharyngitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levocetirizine is the active R-enantiomer of cetirizine, a second-generation antihistamine that selectively antagonizes peripheral H1 receptors. By blocking histamine binding to these receptors, it prevents the cascade of allergic responses including itching, urticaria, and rhinitis without significant central nervous system penetration due to its hydrophilic nature and poor blood-brain barrier crossing.","oneSentence":"Levocetirizine is a selective H1-receptor antagonist that blocks histamine signaling to reduce allergic symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:51:57.775Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis (seasonal and perennial)"},{"name":"Chronic urticaria"},{"name":"Allergic conjunctivitis"}]},"trialDetails":[{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT07341776","phase":"PHASE4","title":"Steroid Use in Treatment of Allergic Reactions to Food","status":"RECRUITING","sponsor":"Johannes Trueck","startDate":"2026-01-26","conditions":"Anaphylactic Reaction, Anaphylaxis, Allergy in Children","enrollment":160},{"nctId":"NCT07365683","phase":"NA","title":"Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria","status":"COMPLETED","sponsor":"Derma Techno Pakistan","startDate":"2025-08-18","conditions":"Chronic Spontaneous Urticaria (CSU)","enrollment":60},{"nctId":"NCT07323888","phase":"NA","title":"Traditional vs. Posterior Nasal Radiofrequency Ablation for Chronic Rhinitis","status":"NOT_YET_RECRUITING","sponsor":"Chien Yu Huang","startDate":"2026-01","conditions":"Nasal Obstruction, Chronic Rhinitis, Nonallergic Rhinitis","enrollment":60},{"nctId":"NCT05637710","phase":"PHASE3","title":"Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-03","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT03545464","phase":"PHASE3","title":"COrticosteroids in acUte uRticAria in emerGency dEpartment","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-21","conditions":"Urticaria, Angiœdema","enrollment":137},{"nctId":"NCT04699604","phase":"PHASE3","title":"A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)","status":"RECRUITING","sponsor":"Bridgette Jones","startDate":"2021-04-28","conditions":"Allergic Asthma","enrollment":300},{"nctId":"NCT06632405","phase":"PHASE2","title":"A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-04-01","conditions":"Breast Cancer","enrollment":60},{"nctId":"NCT06816784","phase":"PHASE2","title":"Treatment Options for Chronic Urticaria","status":"NOT_YET_RECRUITING","sponsor":"Sheikh Zayed Medical College","startDate":"2025-02","conditions":"Chronic Urticaria","enrollment":72},{"nctId":"NCT00789152","phase":"PHASE3","title":"The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Allergic Rhinitis","enrollment":81},{"nctId":"NCT05638880","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2022-12-20","conditions":"Diabetic Nephropathies","enrollment":60},{"nctId":"NCT05565729","phase":"PHASE1","title":"A Phase I Study of LY3471851 in Healthy Participants","status":"COMPLETED","sponsor":"Nektar Therapeutics","startDate":"2022-10-05","conditions":"Healthy","enrollment":41},{"nctId":"NCT00160680","phase":"PHASE4","title":"ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)","status":"COMPLETED","sponsor":"UCB S.A. - Pharma Sector","startDate":"2005-03-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":62},{"nctId":"NCT05348148","phase":"NA","title":"Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis","status":"RECRUITING","sponsor":"Camillians Saint Mary's Hospital Luodong","startDate":"2020-06-16","conditions":"Allergic Rhinitis, Vasomotor Rhinitis","enrollment":450},{"nctId":"NCT00359138","phase":"PHASE4","title":"The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-02","conditions":"Hypersensitivity","enrollment":36},{"nctId":"NCT01392859","phase":"PHASE2, PHASE3","title":"Characterization of the Role of Histamine in Children With Asthma","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2011-06","conditions":"Asthma, Allergic Asthma, Non-allergic Asthma","enrollment":211},{"nctId":"NCT03789422","phase":"PHASE4","title":"Tranexamic Acid and Spontaneous Chronic Urticaria","status":"UNKNOWN","sponsor":"University Hospital, Grenoble","startDate":"2019-12-10","conditions":"Chronic Spontaneous Urticaria","enrollment":80},{"nctId":"NCT00621959","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Seasonal Allergic Rhinitis","enrollment":596},{"nctId":"NCT03590912","phase":"PHASE4","title":"Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion","status":"COMPLETED","sponsor":"Lumbini Medical College","startDate":"2018-09-05","conditions":"Otitis Media With Effusion","enrollment":160},{"nctId":"NCT03555890","phase":"PHASE1","title":"Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-05-18","conditions":"Rhinitis","enrollment":72},{"nctId":"NCT04399525","phase":"NA","title":"Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2019-10-28","conditions":"Pruritus","enrollment":12},{"nctId":"NCT04324918","phase":"PHASE3","title":"Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-10-23","conditions":"Perennial Allergic Rhinitis","enrollment":174},{"nctId":"NCT01586091","phase":"PHASE4","title":"Safety Study of Levocetirizine and Fexofenadine","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2011-02","conditions":"Pruritus, Chronic Urticaria, Allergic Rhinitis","enrollment":18},{"nctId":"NCT03991845","phase":"PHASE4","title":"A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-06-21","conditions":"Urticaria, Vitamin D Deficiency","enrollment":262},{"nctId":"NCT00679250","phase":"PHASE4","title":"To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis","status":"COMPLETED","sponsor":"Brian J Lipworth","startDate":"2005-11","conditions":"Allergic Rhinitis","enrollment":25},{"nctId":"NCT00152464","phase":"PHASE3","title":"Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)","status":"COMPLETED","sponsor":"UCB Pharma SA","startDate":"2002-03-20","conditions":"Dermatitis, Atopic","enrollment":514},{"nctId":"NCT02372604","phase":"PHASE3","title":"Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-07","conditions":"Chronic Spontaneous Urticaria","enrollment":15},{"nctId":"NCT03673384","phase":"NA","title":"Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray Irradiation","status":"COMPLETED","sponsor":"Nanhua University","startDate":"2015-03-02","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT00295022","phase":"PHASE4","title":"Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects","status":"COMPLETED","sponsor":"UCB S.A. - Pharma Sector","startDate":"2006-07-29","conditions":"Rhinitis, Allergic, Seasonal","enrollment":418},{"nctId":"NCT00291642","phase":"PHASE2","title":"A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-01-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":551},{"nctId":"NCT03250143","phase":"PHASE1, PHASE2","title":"To Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory Urticaria","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2016-12-06","conditions":"Chronic Refractory Urticaria","enrollment":56},{"nctId":"NCT03371849","phase":"PHASE1","title":"PK and Safety Study of HCP1102, HGP0813 and HGP1408","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2017-07-19","conditions":"Healthy","enrollment":24},{"nctId":"NCT02447393","phase":"PHASE1","title":"Phase 1 Study of Levocetirizine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03-18","conditions":"Dermatitis","enrollment":20},{"nctId":"NCT00866788","phase":"PHASE2","title":"A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2009-03","conditions":"Chronic Idiopathic Urticaria","enrollment":90},{"nctId":"NCT01622283","phase":"PHASE1","title":"Pharmacokinetic Study of Levocetirizine Oral Solution","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-05-02","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":20},{"nctId":"NCT01722162","phase":"PHASE2","title":"Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-04","conditions":"Colorectal Neoplasms","enrollment":47},{"nctId":"NCT01563081","phase":"PHASE3","title":"Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-04","conditions":"Rhinitis","enrollment":60},{"nctId":"NCT01008592","phase":"","title":"The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism","status":"TERMINATED","sponsor":"Wake Forest University","startDate":"2009-04","conditions":"Rhinitis, Urticaria","enrollment":11},{"nctId":"NCT02551536","phase":"PHASE4","title":"Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis","status":"COMPLETED","sponsor":"Indira Gandhi Medical College, Shimla","startDate":"2014-04","conditions":"Allergic Rhinitis","enrollment":70},{"nctId":"NCT01445262","phase":"","title":"Drug Use Investigation for XYZAL®","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-02","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":10728},{"nctId":"NCT02507635","phase":"PHASE4","title":"Anti-inflammatory H1 Antihistamines Allergic Rhinitis","status":"COMPLETED","sponsor":"Iuliu Hatieganu University of Medicine and Pharmacy","startDate":"2009-02","conditions":"Allergic Rhinitis","enrollment":115},{"nctId":"NCT00619801","phase":"PHASE3","title":"Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Allergic Rhinitis, Chronic Urticaria","enrollment":173},{"nctId":"NCT00628108","phase":"PHASE3","title":"Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Allergic Rhinitis, Chronic Urticaria","enrollment":69},{"nctId":"NCT00160563","phase":"PHASE3","title":"Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)","status":"TERMINATED","sponsor":"UCB Pharma","startDate":"2004-06","conditions":"Asthma","enrollment":207},{"nctId":"NCT00150761","phase":"PHASE4","title":"Facial Thermography Study of Levocetirizine Versus Cetirizine","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-07","conditions":"Anti-allergic Agents","enrollment":60},{"nctId":"NCT00152412","phase":"PHASE2","title":"Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-06","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT00826943","phase":"PHASE4","title":"Is Levocetirizine Less Sedating Than Cetirizine?","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2009-01","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT00521170","phase":"PHASE1","title":"Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-11","conditions":"Allergy","enrollment":""},{"nctId":"NCT00544388","phase":"PHASE3","title":"Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-04","conditions":"Rhinitis, Allergic, Seasonal","enrollment":570},{"nctId":"NCT00160589","phase":"PHASE4","title":"LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-04","conditions":"Rhinitis, Allergic, Perennial","enrollment":729},{"nctId":"NCT00525278","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2003-08","conditions":"Rhinitis, Allergic, Seasonal","enrollment":67},{"nctId":"NCT00524836","phase":"PHASE3","title":"Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2003-09","conditions":"Rhinitis, Allergic, Perennial","enrollment":71},{"nctId":"NCT00521131","phase":"PHASE4","title":"Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2002-09","conditions":"Rhinitis, Allergic, Perennial","enrollment":453},{"nctId":"NCT00315523","phase":"PHASE3","title":"Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-07","conditions":"Rhinitis, Allergic, Seasonal","enrollment":403},{"nctId":"NCT00160537","phase":"PHASE4","title":"POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-05","conditions":"Seasonal Allergic Rhinitis","enrollment":200},{"nctId":"NCT00542607","phase":"PHASE4","title":"Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2002-09","conditions":"Rhinitis, Allergic, Seasonal","enrollment":94},{"nctId":"NCT00525382","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2003-08","conditions":"Urticaria","enrollment":134},{"nctId":"NCT00521040","phase":"NA","title":"Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-02","conditions":"Rhinitis, Allergic, Seasonal","enrollment":459},{"nctId":"NCT00520754","phase":"PHASE2","title":"Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2001-12","conditions":"Cough","enrollment":15},{"nctId":"NCT01496911","phase":"PHASE4","title":"Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving","status":"COMPLETED","sponsor":"Utrecht Institute for Pharmaceutical Sciences","startDate":"2012-04","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT00884325","phase":"PHASE4","title":"Management of Pruritus With Xyzal in Atopic Dermatitis","status":"COMPLETED","sponsor":"Derm Research, PLLC","startDate":"2009-02","conditions":"Atopic Dermatitis, Pruritus","enrollment":40},{"nctId":"NCT01651481","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2012-07","conditions":"Rhinitis","enrollment":28},{"nctId":"NCT01250652","phase":"PHASE4","title":"Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses","status":"COMPLETED","sponsor":"Association Asthma, Bulgaria","startDate":"2011-03","conditions":"Chronic Urticaria","enrollment":24},{"nctId":"NCT01509209","phase":"PHASE3","title":"Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2011-05","conditions":"Vasomotor Rhinitis","enrollment":137},{"nctId":"NCT01640535","phase":"PHASE3","title":"Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2012-06","conditions":"Perennial Allergic Rhinitis","enrollment":283},{"nctId":"NCT01491503","phase":"PHASE1","title":"A Drug Interaction Study of Montelukast and Levocetirizine","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2011-11","conditions":"Healthy","enrollment":30},{"nctId":"NCT01567501","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition","status":"COMPLETED","sponsor":"IPCA Laboratories Ltd.","startDate":"2012-02","conditions":"Fed","enrollment":28},{"nctId":"NCT01557439","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition","status":"COMPLETED","sponsor":"IPCA Laboratories Ltd.","startDate":"2012-02","conditions":"Fasting State","enrollment":28},{"nctId":"NCT01430260","phase":"PHASE4","title":"Omnaris Versus Levocetirizine Phase 4 Study","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2011-01","conditions":"Allergic Rhinitis","enrollment":349},{"nctId":"NCT00598780","phase":"","title":"Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2007-09","conditions":"Rhinitis Allergic, Persistent","enrollment":7870},{"nctId":"NCT00421109","phase":"PHASE3","title":"Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2006-07","conditions":"Urticaria","enrollment":522},{"nctId":"NCT01506063","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2008-01","conditions":"Healthy","enrollment":31},{"nctId":"NCT01506076","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2007-12","conditions":"Fasting","enrollment":29},{"nctId":"NCT00653224","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-04","conditions":"Seasonal Allergic Rhinitis","enrollment":580},{"nctId":"NCT00375713","phase":"PHASE3","title":"Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-10","conditions":"Dermatitis, Eczema","enrollment":466},{"nctId":"NCT00264303","phase":"PHASE4","title":"CUTE (Chronic Urticaria Treatment Evaluation)","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-12","conditions":"Chronic Idiopathic Urticaria","enrollment":886},{"nctId":"NCT01000792","phase":"PHASE3","title":"3-D Visualization of the Anti-Obstructive Effect of Levocetirizine","status":"COMPLETED","sponsor":"Clinical Research International Limited","startDate":"2009-11","conditions":"Allergic Rhinitis","enrollment":1},{"nctId":"NCT01062139","phase":"PHASE4","title":"Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy","status":"UNKNOWN","sponsor":"HK inno.N Corporation","startDate":"2009-10","conditions":"Perennial Allergic Rhinitis","enrollment":100},{"nctId":"NCT00894231","phase":"PHASE4","title":"Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"AAADRS Clinical Research Center","startDate":"2009-01","conditions":"Perennial Allergic Rhinitis","enrollment":30},{"nctId":"NCT00355771","phase":"PHASE4","title":"Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis","status":"COMPLETED","sponsor":"Institut für Atemwegsforschung GmbH","startDate":"2006-06","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT00439712","phase":"PHASE4","title":"Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Institut für Atemwegsforschung GmbH","startDate":"2007-02","conditions":"Perennial Allergic Rhinitis","enrollment":60},{"nctId":"NCT00346606","phase":"PHASE4","title":"The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria","status":"UNKNOWN","sponsor":"Lotus Pharmaceutical","startDate":"2006-01","conditions":"Chronic Idiopathic Urticaria, Urticaria","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Xyzal"],"phase":"marketed","status":"active","brandName":"levocetirizine (Xyzal)","genericName":"levocetirizine (Xyzal)","companyName":"AAADRS Clinical Research Center","companyId":"aaadrs-clinical-research-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levocetirizine is a selective H1-receptor antagonist that blocks histamine signaling to reduce allergic symptoms. Used for Allergic rhinitis (seasonal and perennial), Chronic urticaria, Allergic conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}